In conclusion, the present study, one of the largest evaluating CTA expression in GBM reported to date, found that ACTL8, CTCFL, OIP5 and XAGE3 expression was characteristic of the majority of GBM examined. This evidence concerns the gene XAGE3 and glioblastoma.